Investing
315 Articles
The three major U.S. stock indexes opened lower this morning, and never really got untracked all day. Spanish 10-year bond…
Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in…
The three major U.S. stock indexes opened higher this morning following a report that economic sentiment in Germany came in…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…
The quarterly ExpertRECALL Index released today indicates that more than 123 million medical device units were recalled during the second…
The press recently had a field day with a report from the “Institute for Policy Studies” about executive pay. The…
Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp.…
At the end of two weeks of non-stop second quarter earnings reports, S&P Capital IQ expects a decline of -0.71%…
The three major US stock indexes opened modestly lower this morning as there was little news out of Europe and…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…
The three major US stock indexes opened higher this morning in advance of Fed Chairman Ben Bernanke’s semi-annual report to…
Wednesday is going to mark yet another important day for the early wave of key earnings for this earnings season. …
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment…
Health care products maker Abbott Laboratories (NYSE: ABT) received US Food and Drug Administration approval to market its new glucose…
Our top personal finance-related articles today. Your wallet will thank you later.